Yale University researcher Akiko Iwasaki, Ph.D., says immune profiling shows how Long COVID patients have distinct features not found in control groups. These patients, who also exhibit elevated levels of exhausted T-cells, cause her to express surprise at skeptics.
Iwasaki joins Fiona Lowenstein, editor of “The Long COVID Survival Guide,” to discuss patients who say they’re suffering from Long COVID for as much as two years after their acute phase of the disease.
Iwasaki also explains why her lab’s effort to move forward with a COVID nasal spray faces financial hurdles.
Listen in to this important conversation with hosts Mark Masselli and Margaret Flinter.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
The new Rural Health Transformation Program aims to improve “healthcare access, quality, and outcomes” with…
New research. New technology. New possibilities. On this special 2025 Rewind and Look Ahead episode…
Health care policy faced major upheavals during the past 12 months and the effects are…
Eighty percent of maternal deaths in the United States are considered preventable. So why do…
Originally broadcast December 11, 2025 Congress is scrambling to find a solution to the enhanced…
Originally broadcast December 4, 2025 The doctor who once led the Centers for Disease Control…